(Q44525447)

3 December 2017

title

Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas (English)

1 reference

3 December 2017

Xiao-Bing Wang

1

1 reference

3 December 2017

Xiao-Ying Tian

2

1 reference

3 December 2017

Yang Li

3

1 reference

3 December 2017

Bin Li

4

1 reference

3 December 2017

Zhi Li

5

1 reference

3 December 2017

publication date

3 July 2011

1 reference

Journal of Neuro-Oncology

3 December 2017

published in

1 reference

3 December 2017

volume

106

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

43-51

1 reference

Chemokines and glioma: invasion and more

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Role of MIF in inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor expression in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor contributes angiogenesis by up‐regulating IL‐8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Necrosis as a prognostic factor in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0640-3

Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas

21 January 2018

1 reference

12 December 2020

HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells

1 reference

12 December 2020

Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma.

1 reference

12 December 2020

Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma

1 reference

12 December 2020

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

12 December 2020

Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis

1 reference

12 December 2020

An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.

1 reference

12 December 2020

Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma

1 reference

12 December 2020

Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma

1 reference

12 December 2020

Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.

1 reference

12 December 2020

Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients

1 reference

12 December 2020

10.1007/S11060-011-0640-3

Identifiers

DOI

1 reference

3 December 2017

1 reference